| Year |
Citation |
Score |
| 2024 |
Joyce R, Pascual R, Heitink L, Capaldo BD, Vaillant F, Christie M, Tsai M, Surgenor E, Anttila CJA, Rajasekhar P, Jackling FC, Trussart M, Milevskiy MJG, Song X, Li M, ... ... Visvader JE, et al. Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature Cell Biology. PMID 38216737 DOI: 10.1038/s41556-023-01315-5 |
0.363 |
|
| 2023 |
Milevskiy MJG, Coughlan HD, Kane SR, Johanson TM, Kordafshari S, Chan WF, Tsai M, Surgenor E, Wilcox S, Allan RS, Chen Y, Lindeman GJ, Smyth GK, Visvader JE. Three-dimensional genome architecture coordinates key regulators of lineage specification in mammary epithelial cells. Cell Genomics. 3: 100424. PMID 38020976 DOI: 10.1016/j.xgen.2023.100424 |
0.318 |
|
| 2023 |
Sharma S, Chung CY, Uryu S, Petrovic J, Cao J, Rickard A, Nady N, Greasley S, Johnson E, Brodsky O, Khan S, Wang H, Wang Z, Zhang Y, Tsaparikos K, ... ... Visvader JE, et al. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer. Cell Chemical Biology. PMID 37557181 DOI: 10.1016/j.chembiol.2023.07.005 |
0.355 |
|
| 2023 |
Wang Z, Hu H, Heitink L, Rogers K, You Y, Tan T, Suen CLW, Garnham A, Chen H, Lieschke E, Diepstraten ST, Chang C, Moujalled D, Sutherland K, Lessene G, ... ... Visvader J, et al. The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell Death and Differentiation. PMID 36739334 DOI: 10.1038/s41418-023-01122-3 |
0.34 |
|
| 2022 |
Chen Y, Pal B, Lindeman GJ, Visvader JE, Smyth GK. R code and downstream analysis objects for the scRNA-seq atlas of normal and tumorigenic human breast tissue. Scientific Data. 9: 96. PMID 35322042 DOI: 10.1038/s41597-022-01236-2 |
0.317 |
|
| 2021 |
Wilson MM, Callens C, Le Gallo M, Mironov S, Ding Q, Salamagnon A, Chavarria TE, Viel R, Peasah AD, Bhutkar A, Martin S, Godey F, Tas P, Kang HS, Juin PP, ... ... Visvader JE, et al. An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis. Science Advances. 7: eabf6063. PMID 34705506 DOI: 10.1126/sciadv.abf6063 |
0.318 |
|
| 2021 |
Pal B, Chen Y, Vaillant F, Capaldo BD, Joyce R, Song X, Bryant VL, Penington JS, Di Stefano L, Tubau Ribera N, Wilcox S, Mann GB, Papenfuss AT, Lindeman GJ, ... ... Visvader JE, et al. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. The Embo Journal. e107333. PMID 33950524 DOI: 10.15252/embj.2020107333 |
0.335 |
|
| 2021 |
Holliday H, Roden D, Junankar S, Wu SZ, Baker LA, Krisp C, Chan CL, McFarland A, Skhinas JN, Cox TR, Pal B, Huntington ND, Ormandy CJ, Carroll JS, Visvader J, et al. Inhibitor of Differentiation 4 (ID4) represses mammary myoepithelial differentiation via inhibition of HEB. Iscience. 24: 102072. PMID 33554073 DOI: 10.1016/j.isci.2021.102072 |
0.402 |
|
| 2020 |
Lalaoui N, Merino D, Giner G, Vaillant F, Chau D, Liu L, Kratina T, Pal B, Whittle JR, Etemadi N, Berthelet J, Gräsel J, Hall C, Ritchie ME, Ernst M, ... ... Visvader JE, et al. Targeting triple-negative breast cancers with the Smac-mimetic birinapant. Cell Death and Differentiation. PMID 32341449 DOI: 10.1038/S41418-020-0541-0 |
0.37 |
|
| 2019 |
Dekkers JF, Whittle JR, Vaillant F, Chen HR, Dawson C, Liu K, Geurts M, Herold MJ, Clevers H, Lindeman GJ, Visvader JE. Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids. Journal of the National Cancer Institute. PMID 31589320 DOI: 10.1093/Jnci/Djz196 |
0.35 |
|
| 2019 |
Fu N, Nolan E, Lindeman GJ, Visvader JE. Stem Cells and the Differentiation Hierarchy in Mammary Gland Development. Physiological Reviews. PMID 31539305 DOI: 10.1152/physrev.00040.2018 |
0.403 |
|
| 2019 |
Annunziato S, de Ruiter JR, Henneman L, Brambillasca CS, Lutz C, Vaillant F, Ferrante F, Drenth AP, van der Burg E, Siteur B, van Gerwen B, de Bruijn R, van Miltenburg MH, Huijbers IJ, van de Ven M, ... Visvader JE, et al. Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer. Nature Communications. 10: 397. PMID 30674894 DOI: 10.1038/s41467-019-08301-2 |
0.341 |
|
| 2018 |
Fu NY, Pal B, Chen Y, Jackling FC, Milevskiy M, Vaillant F, Capaldo BD, Guo F, Liu KH, Rios AC, Lim N, Kueh AJ, Virshup DM, Herold MJ, Tucker HO, ... ... Visvader JE, et al. Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from Quiescence. Developmental Cell. 47: 629-644.e8. PMID 30523786 DOI: 10.1016/J.Devcel.2018.10.001 |
0.428 |
|
| 2018 |
Fu NY, Nolan E, Vaillant F, Joyce R, Lindeman G, Visvader J. Abstract IA02: Mapping stem and progenitor cells to decipher the origins of breast cancer Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-Ia02 |
0.507 |
|
| 2017 |
Pal B, Chen Y, Vaillant F, Jamieson P, Gordon L, Rios AC, Wilcox S, Fu N, Liu KH, Jackling FC, Davis MJ, Lindeman GJ, Smyth GK, Visvader JE. Construction of developmental lineage relationships in the mouse mammary gland by single-cell RNA profiling. Nature Communications. 8: 1627. PMID 29158510 DOI: 10.1038/s41467-017-01560-x |
0.321 |
|
| 2017 |
Merino D, Whittle JR, Vaillant F, Serrano A, Gong JN, Giner G, Maragno AL, Chanrion M, Schneider E, Pal B, Li X, Dewson G, Gräsel J, Liu K, Lalaoui N, ... ... Visvader JE, et al. Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer. Science Translational Medicine. 9. PMID 28768804 DOI: 10.1126/Scitranslmed.Aam7049 |
0.316 |
|
| 2017 |
Grassmeyer J, Mukherjee M, deRiso J, Hettinger C, Bailey M, Sinha S, Visvader JE, Zhao H, Fogarty E, Surendran K. Elf5 is a principal cell lineage specific transcription factor in the kidney that contributes to Aqp2 and Avpr2 gene expression. Developmental Biology. PMID 28215940 DOI: 10.1016/J.Ydbio.2017.02.007 |
0.394 |
|
| 2017 |
Fu NY, Rios AC, Pal B, Law CW, Jamieson P, Liu R, Vaillant F, Jackling F, Liu KH, Smyth GK, Lindeman GJ, Ritchie ME, Visvader JE. Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive. Nature Cell Biology. PMID 28192422 DOI: 10.1038/ncb3471 |
0.377 |
|
| 2017 |
Nolan E, Lindeman GJ, Visvader JE. Out-RANKing BRCA1 in Mutation Carriers. Cancer Research. PMID 28104682 DOI: 10.1158/0008-5472.CAN-16-2025 |
0.344 |
|
| 2017 |
van de Moosdijk AA, Fu NY, Rios AC, Visvader JE, van Amerongen R. Lineage Tracing of Mammary Stem and Progenitor Cells. Methods in Molecular Biology (Clifton, N.J.). 1501: 291-308. PMID 27796960 DOI: 10.1007/978-1-4939-6475-8_15 |
0.34 |
|
| 2017 |
Lindeman GJ, Lok SW, Bergin AR, Whittle JR, Shackleton K, Sherman P, Dawson S, Desai J, Liew D, Mann B, Murugasu A, Roberts AW, Rosenthal M, Visvader J. Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study. Journal of Clinical Oncology. 35: 1044-1044. DOI: 10.1200/Jco.2017.35.15_Suppl.1044 |
0.306 |
|
| 2016 |
O'Brien CM, Chy HS, Zhou Q, Blumenfeld S, Lambshead JW, Liu X, Kie J, Capaldo BD, Chung TL, Adams TE, Phan T, Bentley JD, Mckinstry WJ, Oliva K, Mcmurrick PJ, ... ... Visvader JE, et al. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells. Stem Cells (Dayton, Ohio). PMID 28009074 DOI: 10.1002/Stem.2558 |
0.303 |
|
| 2016 |
Rios AC, Fu NY, Cursons J, Lindeman GJ, Visvader JE. The complexities and caveats of lineage tracing in the mammary gland. Breast Cancer Research : Bcr. 18: 116. PMID 27887631 DOI: 10.1186/s13058-016-0774-5 |
0.317 |
|
| 2016 |
Nolan E, Vaillant F, Branstetter D, Pal B, Giner G, Whitehead L, Lok SW, Mann GB, Rohrbach K, Huang LY, Soriano R, Smyth GK, Dougall WC, Visvader JE, et al. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. Nature Medicine. PMID 27322743 DOI: 10.1038/nm.4118 |
0.349 |
|
| 2016 |
Sau A, Lau R, Cabrita MA, Nolan E, Crooks PA, Visvader JE, Pratt MA. Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage. Cell Stem Cell. PMID 27292187 DOI: 10.1016/J.Stem.2016.05.003 |
0.326 |
|
| 2016 |
Rios AC, Fu NY, Jamieson PR, Pal B, Whitehead L, Nicholas KR, Lindeman GJ, Visvader JE. Essential role for a novel population of binucleated mammary epithelial cells in lactation. Nature Communications. 7: 11400. PMID 27102712 DOI: 10.1038/Ncomms11400 |
0.313 |
|
| 2015 |
Sutherland KD, Visvader JE. Cellular Mechanisms Underlying Intertumoral Heterogeneity. Trends in Cancer. 1: 15-23. PMID 28741558 DOI: 10.1016/j.trecan.2015.07.003 |
0.344 |
|
| 2015 |
Merino D, Lok SW, Visvader JE, Lindeman GJ. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer. Oncogene. PMID 26257067 DOI: 10.1038/onc.2015.287 |
0.31 |
|
| 2015 |
Sheridan JM, Ritchie ME, Best SA, Jiang K, Beck TJ, Vaillant F, Liu K, Dickins RA, Smyth GK, Lindeman GJ, Visvader JE. A pooled shRNA screen for regulators of primary mammary stem and progenitor cells identifies roles for Asap1 and Prox1. Bmc Cancer. 15: 221. PMID 25879659 DOI: 10.1186/S12885-015-1187-Z |
0.467 |
|
| 2015 |
Fu NY, Rios AC, Pal B, Soetanto R, Lun AT, Liu K, Beck T, Best SA, Vaillant F, Bouillet P, Strasser A, Preiss T, Smyth GK, Lindeman GJ, Visvader JE. EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival. Nature Cell Biology. 17: 365-75. PMID 25730472 DOI: 10.1038/ncb3117 |
0.333 |
|
| 2015 |
Merino D, Best SA, Asselin-Labat ML, Vaillant F, Pal B, Dickins RA, Anderson RL, Strasser A, Bouillet P, Lindeman GJ, Visvader JE. Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2. Oncogene. 34: 3926-34. PMID 25263453 DOI: 10.1038/Onc.2014.313 |
0.474 |
|
| 2014 |
Owens TW, Rogers RL, Best SA, Ledger A, Mooney AM, Ferguson A, Shore P, Swarbrick A, Ormandy CJ, Simpson PT, Carroll JS, Visvader JE, Naylor MJ. Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. Cancer Research. 74: 5277-86. PMID 25056120 DOI: 10.1158/0008-5472.CAN-14-0053 |
0.478 |
|
| 2014 |
Best SA, Hutt KJ, Fu NY, Vaillant F, Liew SH, Hartley L, Scott CL, Lindeman GJ, Visvader JE. Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary. Development (Cambridge, England). 141: 3159-64. PMID 25038044 DOI: 10.1242/dev.108498 |
0.392 |
|
| 2014 |
Visvader JE, Stingl J. Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes & Development. 28: 1143-58. PMID 24888586 DOI: 10.1101/gad.242511.114 |
0.392 |
|
| 2014 |
Godde NJ, Sheridan JM, Smith LK, Pearson HB, Britt KL, Galea RC, Yates LL, Visvader JE, Humbert PO. Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. Plos Genetics. 10: e1004323. PMID 24852022 DOI: 10.1371/journal.pgen.1004323 |
0.388 |
|
| 2014 |
Rios AC, Fu NY, Lindeman GJ, Visvader JE. In situ identification of bipotent stem cells in the mammary gland. Nature. 506: 322-7. PMID 24463516 DOI: 10.1038/nature12948 |
0.332 |
|
| 2014 |
Fu N, Lindeman GJ, Visvader JE. The mammary stem cell hierarchy. Current Topics in Developmental Biology. 107: 133-60. PMID 24439805 DOI: 10.1016/B978-0-12-416022-4.00005-6 |
0.408 |
|
| 2013 |
Knower KC, Chand AL, Eriksson N, Takagi K, Miki Y, Sasano H, Visvader JE, Lindeman GJ, Funder JW, Fuller PJ, Simpson ER, Tilley WD, Leedman PJ, Graham J, Muscat GE, et al. Distinct nuclear receptor expression in stroma adjacent to breast tumors. Breast Cancer Research and Treatment. 142: 211-23. PMID 24122391 DOI: 10.1007/s10549-013-2716-6 |
0.338 |
|
| 2013 |
Stokes PH, Liew CW, Kwan AH, Foo P, Barker HE, Djamirze A, O'Reilly V, Visvader JE, Mackay JP, Matthews JM. Structural basis of the interaction of the breast cancer oncogene LMO4 with the tumour suppressor CtIP/RBBP8. Journal of Molecular Biology. 425: 1101-10. PMID 23353824 DOI: 10.1016/J.Jmb.2013.01.017 |
0.335 |
|
| 2013 |
Rios A, Fu N, Pal B, Lindeman G, Visvader J. Abstract IA12: Mammary epithelial subtypes and their implications for breast cancer Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-Ia12 |
0.527 |
|
| 2012 |
Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 10: 717-28. PMID 22704512 DOI: 10.1016/j.stem.2012.05.007 |
0.322 |
|
| 2012 |
Eirew P, Kannan N, Knapp DJ, Vaillant F, Emerman JT, Lindeman GJ, Visvader JE, Eaves CJ. Aldehyde dehydrogenase activity is a biomarker of primitive normal human mammary luminal cells. Stem Cells (Dayton, Ohio). 30: 344-8. PMID 22131125 DOI: 10.1002/Stem.1001 |
0.424 |
|
| 2012 |
Oakes S, Vaillant F, Lim E, Lee L, Breslin K, Feleppa F, Deb S, Ritchie M, Takano E, Ward T, Fox S, Generali D, Smyth G, Strasser A, Huang D, ... Visvader J, et al. Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S2-A25 |
0.419 |
|
| 2011 |
Asselin-Labat ML, Lindeman GJ, Visvader JE. Mammary stem cells and their regulation by steroid hormones. Expert Review of Endocrinology & Metabolism. 6: 371-381. PMID 30754117 DOI: 10.1586/eem.11.22 |
0.377 |
|
| 2011 |
Visvader JE, Lindeman GJ. The unmasking of novel unipotent stem cells in the mammary gland. The Embo Journal. 30: 4858-9. PMID 22068053 DOI: 10.1038/emboj.2011.415 |
0.319 |
|
| 2011 |
Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, Deb S, Fox SB, Smyth GK, Lindeman GJ, Visvader JE. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Molecular and Cellular Biology. 31: 4609-22. PMID 21930782 DOI: 10.1128/MCB.05766-11 |
0.373 |
|
| 2011 |
Ji H, Goode RJ, Vaillant F, Mathivanan S, Kapp EA, Mathias RA, Lindeman GJ, Visvader JE, Simpson RJ. Proteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations. Proteomics. 11: 4029-39. PMID 21834135 DOI: 10.1002/Pmic.201100102 |
0.35 |
|
| 2011 |
Lee HJ, Hinshelwood RA, Bouras T, Gallego-Ortega D, Valdés-Mora F, Blazek K, Visvader JE, Clark SJ, Ormandy CJ. Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. Stem Cells (Dayton, Ohio). 29: 1611-9. PMID 21823211 DOI: 10.1002/stem.706 |
0.351 |
|
| 2011 |
Lindeman GJ, Visvader JE. Cell fate takes a slug in BRCA1-associated breast cancer. Breast Cancer Research : Bcr. 13: 306. PMID 21489318 DOI: 10.1186/bcr2840 |
0.463 |
|
| 2011 |
Smart CE, Wronski A, French JD, Edwards SL, Asselin-Labat ML, Waddell N, Peters K, Brewster BL, Brooks K, Simpson K, Manning N, Lakhani SR, Grimmond S, Lindeman GJ, Visvader JE, et al. Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit. Oncogene. 30: 1597-607. PMID 21132007 DOI: 10.1038/onc.2010.538 |
0.405 |
|
| 2011 |
Visvader JE, Smith GH. Murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harbor Perspectives in Biology. 3. PMID 20926515 DOI: 10.1101/cshperspect.a004879 |
0.375 |
|
| 2011 |
Asselin-Labat ML, Lindeman GJ, Visvader JE. Mammary stem cells and their regulation by steroid hormones Expert Review of Endocrinology and Metabolism. 6: 371-381. DOI: 10.1586/eem.11.22 |
0.349 |
|
| 2010 |
Montañez-Wiscovich ME, Shelton MD, Seachrist DD, Lozada KL, Johnson E, Miedler JD, Abdul-Karim FW, Visvader JE, Keri RA. Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells. The Journal of Pathology. 222: 271-81. PMID 20814902 DOI: 10.1002/Path.2762 |
0.394 |
|
| 2010 |
Visvader JE, Lindeman GJ. Stem cells and cancer - the promise and puzzles. Molecular Oncology. 4: 369-72. PMID 20692213 DOI: 10.1016/j.molonc.2010.07.001 |
0.309 |
|
| 2010 |
Lindeman GJ, Visvader JE. Insights into the cell of origin in breast cancer and breast cancer stem cells. Asia-Pacific Journal of Clinical Oncology. 6: 89-97. PMID 20565420 DOI: 10.1111/j.1743-7563.2010.01279.x |
0.343 |
|
| 2010 |
Bernardo GM, Lozada KL, Miedler JD, Harburg G, Hewitt SC, Mosley JD, Godwin AK, Korach KS, Visvader JE, Kaestner KH, Abdul-Karim FW, Montano MM, Keri RA. FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development (Cambridge, England). 137: 2045-54. PMID 20501593 DOI: 10.1242/Dev.043299 |
0.642 |
|
| 2010 |
Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE. Control of mammary stem cell function by steroid hormone signalling. Nature. 465: 798-802. PMID 20383121 DOI: 10.1038/nature09027 |
0.367 |
|
| 2010 |
Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, Vaillant F, Yagita H, Lindeman GJ, Smyth GK, Visvader JE. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Research : Bcr. 12: R21. PMID 20346151 DOI: 10.1186/bcr2560 |
0.366 |
|
| 2010 |
Murphy NC, Biankin AV, Millar EK, McNeil CM, O'Toole SA, Segara D, Crea P, Olayioye MA, Lee CS, Fox SB, Morey AL, Christie M, Musgrove EA, Daly RJ, Lindeman GJ, ... ... Visvader JE, et al. Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status. International Journal of Cancer. Journal International Du Cancer. 126: 1445-53. PMID 19676041 DOI: 10.1002/ijc.24826 |
0.321 |
|
| 2009 |
Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes & Development. 23: 2563-77. PMID 19933147 DOI: 10.1101/gad.1849509 |
0.375 |
|
| 2009 |
Taylor RA, Wang H, Wilkinson SE, Richards MG, Britt KL, Vaillant F, Lindeman GJ, Visvader JE, Cunha GR, St John J, Risbridger GP. Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers. Stem Cells (Dayton, Ohio). 27: 3032-42. PMID 19862839 DOI: 10.1002/stem.244 |
0.348 |
|
| 2009 |
Gyorki DE, Asselin-Labat ML, van Rooijen N, Lindeman GJ, Visvader JE. Resident macrophages influence stem cell activity in the mammary gland. Breast Cancer Research : Bcr. 11: R62. PMID 19706193 DOI: 10.1186/bcr2353 |
0.363 |
|
| 2009 |
Montañez-Wiscovich ME, Seachrist DD, Landis MD, Visvader J, Andersen B, Keri RA. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene. 28: 3608-18. PMID 19648968 DOI: 10.1038/Onc.2009.221 |
0.517 |
|
| 2009 |
Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, Fox SB, ... ... Visvader JE, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Medicine. 15: 907-13. PMID 19648928 DOI: 10.1038/nm.2000 |
0.377 |
|
| 2009 |
Shackleton M, O'Reilly LA, Sutherland KD, Bath ML, Ellis S, Strasser A, Visvader JE, Lindeman GJ. Impaired lactation in mice expressing dominant-negative FADD in mammary epithelium. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 238: 1010-6. PMID 19301394 DOI: 10.1002/Dvdy.21917 |
0.392 |
|
| 2009 |
Huang Z, Kawase-Koga Y, Zhang S, Visvader J, Toth M, Walsh CA, Sun T. Transcription factor Lmo4 defines the shape of functional areas in developing cortices and regulates sensorimotor control. Developmental Biology. 327: 132-42. PMID 19111533 DOI: 10.1016/J.Ydbio.2008.12.003 |
0.359 |
|
| 2008 |
Asselin-Labat ML, Vaillant F, Shackleton M, Bouras T, Lindeman GJ, Visvader JE. Delineating the epithelial hierarchy in the mouse mammary gland. Cold Spring Harbor Symposia On Quantitative Biology. 73: 469-78. PMID 19022771 DOI: 10.1101/Sqb.2008.73.020 |
0.461 |
|
| 2008 |
Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat ML, Oakes SR, Lindeman GJ, Visvader JE. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell. 3: 429-41. PMID 18940734 DOI: 10.1016/j.stem.2008.08.001 |
0.634 |
|
| 2008 |
Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Research. 68: 7711-7. PMID 18829523 DOI: 10.1158/0008-5472.Can-08-1949 |
0.352 |
|
| 2008 |
Barker HE, Smyth GK, Wettenhall J, Ward TA, Bath ML, Lindeman GJ, Visvader JE. Deaf-1 regulates epithelial cell proliferation and side-branching in the mammary gland. Bmc Developmental Biology. 8: 94. PMID 18826651 DOI: 10.1186/1471-213X-8-94 |
0.436 |
|
| 2008 |
Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews. Cancer. 8: 755-68. PMID 18784658 DOI: 10.1038/nrc2499 |
0.306 |
|
| 2008 |
Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer PL, Lindeman GJ, Visvader JE, Ormandy CJ. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes & Development. 22: 581-6. PMID 18316476 DOI: 10.1101/Gad.1614608 |
0.339 |
|
| 2007 |
Vaillant F, Asselin-Labat ML, Shackleton M, Lindeman GJ, Visvader JE. The emerging picture of the mouse mammary stem cell. Stem Cell Reviews. 3: 114-23. PMID 17873344 DOI: 10.1007/S12015-007-0018-2 |
0.394 |
|
| 2007 |
Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nature Cell Biology. 9: 201-9. PMID 17187062 DOI: 10.1038/Ncb1530 |
0.481 |
|
| 2006 |
Sutherland KD, Vaillant F, Alexander WS, Wintermantel TM, Forrest NC, Holroyd SL, McManus EJ, Schutz G, Watson CJ, Chodosh LA, Lindeman GJ, Visvader JE. c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. The Embo Journal. 25: 5805-15. PMID 17139252 DOI: 10.1038/Sj.Emboj.7601455 |
0.31 |
|
| 2006 |
Visvader JE, Lindeman GJ. Mammary stem cells and mammopoiesis. Cancer Research. 66: 9798-801. PMID 17047038 DOI: 10.1158/0008-5472.CAN-06-2254 |
0.384 |
|
| 2006 |
Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research. 66: 9339-44. PMID 16990346 DOI: 10.1158/0008-5472.Can-06-3126 |
0.424 |
|
| 2006 |
Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, Visvader JE, Lindeman GJ. Steroid hormone receptor status of mouse mammary stem cells. Journal of the National Cancer Institute. 98: 1011-4. PMID 16849684 DOI: 10.1093/Jnci/Djj267 |
0.451 |
|
| 2006 |
Harris J, Stanford PM, Sutherland K, Oakes SR, Naylor MJ, Robertson FG, Blazek KD, Kazlauskas M, Hilton HN, Wittlin S, Alexander WS, Lindeman GJ, Visvader JE, Ormandy CJ. Socs2 and elf5 mediate prolactin-induced mammary gland development. Molecular Endocrinology (Baltimore, Md.). 20: 1177-87. PMID 16469767 DOI: 10.1210/me.2005-0473 |
0.37 |
|
| 2006 |
Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. Generation of a functional mammary gland from a single stem cell. Nature. 439: 84-8. PMID 16397499 DOI: 10.1038/Nature04372 |
0.387 |
|
| 2005 |
Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL, Lindeman GJ, Visvader JE. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 102: 7659-64. PMID 15897450 DOI: 10.1073/pnas.0502990102 |
0.404 |
|
| 2005 |
Sum EY, Shackleton M, Hahm K, Thomas RM, O'Reilly LA, Wagner KU, Lindeman GJ, Visvader JE. Loss of the LIM domain protein Lmo4 in the mammary gland during pregnancy impedes lobuloalveolar development. Oncogene. 24: 4820-8. PMID 15856027 DOI: 10.1038/Sj.Onc.1208638 |
0.385 |
|
| 2005 |
Sum EY, O'Reilly LA, Jonas N, Lindeman GJ, Visvader JE. The LIM domain protein Lmo4 is highly expressed in proliferating mouse epithelial tissues. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 53: 475-86. PMID 15805422 DOI: 10.1369/jhc.4A6553.2005 |
0.392 |
|
| 2005 |
Zhou J, Chehab R, Tkalcevic J, Naylor MJ, Harris J, Wilson TJ, Tsao S, Tellis I, Zavarsek S, Xu D, Lapinskas EJ, Visvader J, Lindeman GJ, Thomas R, Ormandy CJ, et al. Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. The Embo Journal. 24: 635-44. PMID 15650748 DOI: 10.1038/Sj.Emboj.7600538 |
0.416 |
|
| 2004 |
Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W, Campbell IG, Visvader JE. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene. 23: 7726-33. PMID 15361843 DOI: 10.1038/sj.onc.1207787 |
0.365 |
|
| 2004 |
Olayioye MA, Hoffmann P, Pomorski T, Armes J, Simpson RJ, Kemp BE, Lindeman GJ, Visvader JE. The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation. Cancer Research. 64: 3538-44. PMID 15150109 DOI: 10.1158/0008-5472.Can-03-3731 |
0.346 |
|
| 2004 |
Hahm K, Sum EY, Fujiwara Y, Lindeman GJ, Visvader JE, Orkin SH. Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Molecular and Cellular Biology. 24: 2074-82. PMID 14966286 DOI: 10.1128/Mcb.24.5.2074-2082.2004 |
0.352 |
|
| 2003 |
Wittlin S, Sutherland KD, Visvader JE, Lindeman GJ. Identification of Taxreb107 as a lactogenic hormone responsive gene in mammary epithelial cells. Biochimica Et Biophysica Acta. 1642: 139-47. PMID 14572897 DOI: 10.1016/S0167-4889(03)00121-6 |
0.361 |
|
| 2003 |
Sutherland KD, Visvader JE, Choong DY, Sum EY, Lindeman GJ, Campbell IG. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas. International Journal of Cancer. Journal International Du Cancer. 107: 155-8. PMID 12925972 DOI: 10.1002/ijc.11343 |
0.332 |
|
| 2003 |
Wittlin S, Sum EY, Jonas NK, Lindeman GJ, Visvader JE. Two promoters within the human LMO4 gene contribute to its overexpression in breast cancer cells. Genomics. 82: 280-7. PMID 12906853 DOI: 10.1016/S0888-7543(03)00147-2 |
0.423 |
|
| 2003 |
Ormandy CJ, Naylor M, Harris J, Robertson F, Horseman ND, Lindeman GJ, Visvader J, Kelly PA. Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Progress in Hormone Research. 58: 297-323. PMID 12795425 DOI: 10.1210/Rp.58.1.297 |
0.421 |
|
| 2003 |
Visvader JE, Lindeman GJ. Transcriptional regulators in mammary gland development and cancer. The International Journal of Biochemistry & Cell Biology. 35: 1034-51. PMID 12672473 DOI: 10.1016/S1357-2725(03)00030-X |
0.425 |
|
| 2002 |
Peng B, Sutherland KD, Sum EY, Olayioye M, Wittlin S, Tang TK, Lindeman GJ, Visvader JE. CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity. Molecular Endocrinology (Baltimore, Md.). 16: 2019-33. PMID 12198240 DOI: 10.1210/me.2002-0108 |
0.346 |
|
| 2002 |
Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, Visvader JE. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. The Journal of Biological Chemistry. 277: 7849-56. PMID 11751867 DOI: 10.1074/Jbc.M110603200 |
0.32 |
|
| 2001 |
Visvader JE, Venter D, Hahm K, Santamaria M, Sum EY, O'Reilly L, White D, Williams R, Armes J, Lindeman GJ. The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 98: 14452-7. PMID 11734645 DOI: 10.1073/pnas.251547698 |
0.431 |
|
| 2001 |
Lindeman GJ, Wittlin S, Lada H, Naylor MJ, Santamaria M, Zhang JG, Starr R, Hilton DJ, Alexander WS, Ormandy CJ, Visvader J. SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes & Development. 15: 1631-6. PMID 11445538 DOI: 10.1101/Gad.880801 |
0.376 |
|
| 2000 |
O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML, Huang DC, Strasser A. The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. The American Journal of Pathology. 157: 449-61. PMID 10934149 DOI: 10.1016/S0002-9440(10)64557-9 |
0.405 |
|
| 1998 |
Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR, Orkin SH. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes & Development. 12: 2392-402. PMID 9694803 DOI: 10.1101/Gad.12.15.2392 |
0.357 |
|
| 1998 |
Ogilvy S, Elefanty AG, Visvader J, Bath ML, Harris AW, Adams JM. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood. 91: 419-30. PMID 9427694 DOI: 10.1182/Blood.V91.2.419.419_419_430 |
0.405 |
|
| 1997 |
Visvader JE, Mao X, Fujiwara Y, Hahm K, Orkin SH. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proceedings of the National Academy of Sciences of the United States of America. 94: 13707-12. PMID 9391090 DOI: 10.1073/Pnas.94.25.13707 |
0.32 |
|
| 1997 |
Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M, Orkin SH. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell. 90: 109-19. PMID 9230307 DOI: 10.1016/S0092-8674(00)80318-9 |
0.349 |
|
| 1995 |
Visvader JE, Crossley M, Hill J, Orkin SH, Adams JM. The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Molecular and Cellular Biology. 15: 634-41. PMID 7823932 DOI: 10.1128/Mcb.15.2.634 |
0.317 |
|
| 1994 |
Begley CG, Robb L, Rockman S, Visvader J, Bockamp EO, Chan YS, Green AR. Structure of the gene encoding the murine SCL protein. Gene. 138: 93-9. PMID 8125323 DOI: 10.1016/0378-1119(94)90787-0 |
0.329 |
|
| 1993 |
Visvader J, Adams JM. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood. 82: 1493-501. PMID 7689871 DOI: 10.1182/Blood.V82.5.1493.1493 |
0.449 |
|
| 1992 |
Green AR, Lints T, Visvader J, Harvey R, Begley CG. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene. 7: 653-60. PMID 1565464 |
0.358 |
|
| 1992 |
Visvader JE, Elefanty AG, Strasser A, Adams JM. GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. The Embo Journal. 11: 4557-64. PMID 1385117 |
0.38 |
|
| 1991 |
Visvader J, Begley CG, Adams JM. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene. 6: 187-94. PMID 2000219 |
0.335 |
|
| 1991 |
Visvader J, Begley CG. Helix-loop-helix genes translocated in lymphoid leukemia. Trends in Biochemical Sciences. 16: 330-3. PMID 1949153 DOI: 10.1016/0968-0004(91)90137-K |
0.374 |
|
| 1990 |
Perkins A, Kongsuwan K, Visvader J, Adams JM, Cory S. Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 87: 8398-402. PMID 1978323 DOI: 10.1073/Pnas.87.21.8398 |
0.336 |
|
| 1989 |
Visvader J, Verma IM. Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes. Molecular and Cellular Biology. 9: 1336-41. PMID 2524648 DOI: 10.1128/Mcb.9.3.1336 |
0.383 |
|
| 1988 |
Sassone-Corsi P, Visvader J, Ferland L, Mellon PL, Verma IM. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes & Development. 2: 1529-38. PMID 2850967 DOI: 10.1101/Gad.2.12A.1529 |
0.378 |
|
| Show low-probability matches. |